Volume 15, Issue 9 (9-2017)                   IJRM 2017, 15(9): 553-560 | Back to browse issues page


XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Bazarganipour F, Taghavi S A, Allan H, Hosseini N. Facilitating and inhibiting factors related to treatment adherence in women with polycystic ovary syndrome: A qualitative study. IJRM. 2017; 15 (9) :553-560
URL: http://journals.ssu.ac.ir/ijrmnew/article-1-858-en.html
1- Social Determinants of Health Research Center, Yasuj University of Medical Sciences, Yasuj, Iran , hosseinichenar@yahoo.com
2- Fertility and Infertility Research Center, Hormozgan University of Medical Sciences, Bandar Abbas, Iran
3- Centre for Critical Research in Nursing and Midwifery, School of Health and Education, Middlesex University, London, England
4- Social Determinants of Health Research Center, Yasuj University of Medical Sciences, Yasuj, Iran
Abstract:   (690 Views)
Background: Adherence issues in polycystic ovary syndrome (PCOS) patients have not been examined thoroughly. Patients report prolonged periods of treatment and side effects of the drug as the most common reason for withdrawal from treatment. To improve the effective management of PCOS patients, it is fundamental to understand facilitating and inhibiting factors to treatment adherence.
Objective: To explore facilitating/inhibiting factors related to treatment adherence among PCOS patients.
Materials and Methods: This was a qualitative study with a purposive sample of women with confirmed diagnosis of PCOS. The data were collected via 20 in-depth semi-structured interviews with women aged between 21-34 yr. A qualitative content analysis was used to analyze the data.
Results: Five themes were identified which described different types of facilitating/ inhibiting factors to treatment adherence. Inhibiting factors included financial issues, patient-related, disease-related, and health care provider-related factors; while social factors were found to be both facilitating and inhibiting.
Conclusion: The findings suggest that successful adherence to PCOS treatment is highly dependent on patients recognizing and adapting to financial, social, and health care related inhibiting factors. It is also crucial for clinicians and policy makers to recognize these key inhibiting factors in order to improve treatment outcomes.
Full-Text [PDF 261 kb]   (209 Downloads) |   |   Full-Text (HTML)  (52 Views)  
Type of Study: Original Article |

References
1. Tejera A, Molla M, Muriel L, Remohi J, Pellicer A, De Pablo JL. Successful pregnancy and childbirth after intracytoplasmic sperm injection with calcium ionophore oocyte activation in a globozoospermic patient. Fertil Steril 2008; 90: 1202. [DOI:10.1016/j.fertnstert.2007.11.056]
2. Hahn S, Janssen OE, Tan S, Pleger K, Mann K, chedlowski M, et al. Clinical and psychological correlates of quality-of-life in polycystic ovary syndrome. Eur J Endocrinol 2005; 153: 853-860. [DOI:10.1530/eje.1.02024]
3. Goolsby MJ. AACE Hyperandrogenism Guidelines. J Am Acad Nurse Pract 2001; 13: 492-494. [DOI:10.1111/j.1745-7599.2001.tb00013.x]
4. Hsieh HF, Shannon SE. Three approaches to qualitative content analysis. Qual Health Res 2005; 15: 1277-1288. [DOI:10.1177/1049732305276687]
5. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Fertil Steril 2004; 81:19-25. [DOI:10.1016/j.fertnstert.2003.10.004]
6. Berg JS, Dischler J, Wagner DJ, Raia JJ, Palmer-Shevlin N. Medication compliance: a healthcare problem. Ann Pharmacother 1993; 27: S1-24.
7. Benjamin RM. Medication adherence: helping patients take their medicines as directed. Public Health Rep 2012; 127: 2-3. [DOI:10.1177/003335491212700102]
8. ElInati E, Kuentz P, Redin C, Jaber S, Meerschaut FV, Makarian J, et al. Globozoospermia is mainly due to DPY19L2 deletion via non-allelic homologous recombination involving two recombination hotspots. Hum Mol Genet 2012; 21: 3695-3702. [DOI:10.1093/hmg/dds200]
9. Ferriman D, Gallwey JD. Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 1961; 21: 1440-1447. [DOI:10.1210/jcem-21-11-1440]
10. Barber MD, Walters MD, Bump RC. Short forms of two condition-specific quality-of-life questionnaires for women with pelvic floor disorders (PFDI-20 and PFIQ-7). Am J Obstet Gynecol 2005; 193: 103-113. [DOI:10.1016/j.ajog.2004.12.025]
11. Montazeri A, Goshtasebi A, Vahdaninia M. Educational inequalities in self-reported health in a general Iranian population. BMC Res Notes 2008; 1: 50. [DOI:10.1186/1756-0500-1-50]
12. Zhang HY, Zhu FF, Xiong J, Shi XB, Fu SX. Characteristics of different phenotypes of polycystic ovary syndrome based on the Rotterdam criteria in a large-scale Chinese population. BJOG 2009; 116: 1633-1639. [DOI:10.1111/j.1471-0528.2009.02347.x]
13. Gilpin SA, Gosling JA, Smith AR, Warrell DW. The pathogenesis of genitourinary prolapse and stress incontinence of urine. A histological and histochemical study. Br J Obstet Gynaecol 1989; 96: 15-23. [DOI:10.1111/j.1471-0528.1989.tb01570.x]
14. Bukovsky A, Indrapichate K, Fujiwara H, Cekanova M, Ayala ME, Dominguez R, et al. Multiple luteinizing hormone receptor (LHR) protein variants, interspecies reactivity of anti-LHR mAb clone 3B5, subcellular localization of LHR in human placenta, pelvic floor and brain, and possible role for LHR in the development of abnormal pregnancy, pelvic floor disorders and Alzheimer's disease. Reprod Biol Endocrinol 2003; 1: 46. [DOI:10.1186/1477-7827-1-46]
15. Frank L, Kleinman L, Rentz A, Ciesla G, Kim JJ, Zacker C. Health-related quality of life associated with irritable bowel syndrome: comparison with other chronic diseases. Clin Ther 2002; 24: 675-689. [DOI:10.1016/S0149-2918(02)85143-8]
16. McEvan MJ, Espie CA, Metcalfe J. A systematic review of the contribution of qualitative research to the study of quality of life in children and adolescents with epilepsy. Seizure 2004: 13: 3-17. [DOI:10.1016/S1059-1311(03)00081-5]
17. Pitts M, Phillips K. The psychology of health: an introduction. 2nd Ed. New york, Psychology Press; 1998
18. Lewis MP, Colbert A, Erlen J, Meyers M. A qualitative study of persons who are 100% adherent to antiretroviral therapy. AIDS Care 2006; 18: 140-148. [DOI:10.1080/09540120500161835]
19. Coetzee D, Boulle A, Hildebrand K, Asselman V, Van Cutsem G, Goemaere E. Promoting adherence to antiretroviral therapy: the experience from a primary care setting in Khayelitsha, South Africa. AIDS 2004; 18: S27-31. [DOI:10.1097/00002030-200406003-00006]
20. Weber AM, Abrams P, Brubaker L, Cundiff G, Davis G, Dmochowski RR, et al. The standardization of terminology for researchers in female pelvic floor disorders. Int Urogynecol J Pelvic Floor Dysfunct 2001; 12: 178-186. [DOI:10.1007/PL00004033]
21. Yamano S, Nakagawa K, Nakasaka H, Aono T. Fertilization failure and oocyte activation. J Med Invest 2000; 47: 1-8.
22. Sun F, Ko E, Martin RH. Is there a relationship between sperm chromosome abnormalities and sperm morphology? Reprod Biol Endocrinol 2006; 4: 1. [DOI:10.1186/1477-7827-4-1]
23. DiMatteo MR. Social support and patient adherence to medical treatment: a meta-analysis. Health Psychol 2004; 23: 207-218. [DOI:10.1037/0278-6133.23.2.207]
24. Park H, Hong Y, Lee H, Ha E, Sung Y. Individuals with type 2 diabetes and depressive symptoms exhibited lower adherence with self-care. J Clin Epidemiol 2004; 57: 978-984 [DOI:10.1016/j.jclinepi.2004.01.015]
25. Nagelkerk J, Reick K, Meengs L. Perceived barriers and effective strategies to diabetes self-management. J Adv Nurs 2006; 54: 151-158. [DOI:10.1111/j.1365-2648.2006.03799.x]
26. Vincze G, Barner JC, Lopez D. Factors associated with adherence to self-monitoring of blood glucose among persons with diabetes. Diabetes Educ 2004; 30: 112-125. [DOI:10.1177/014572170403000119]
27. Jallinoja P., Pajari P., Absetz P. Repertoires of lifestyle change and self-responsibility among participants in an intervention to prevent type 2 diabetes. Scand J Caring Sci 2008; 22: 455-462. [DOI:10.1111/j.1471-6712.2007.00551.x]
28. Penn L, Moffat SM, White M. Participants" perspectives on maintaining behaviour change: a qualitative study within the European Diabetes Prevention Study. BMC Public Health 2008; 8: 235. [DOI:10.1186/1471-2458-8-235]
29. Korkiakangas E., Taanila AM., Keinanen-Kiukaanniemi S. Motivation to physical activity among adults with high risk of type 2 diabetes who participated in the Oulu substudy of the Finnish Diabetes Prevention Study. Health Soc Care Community 2011; 19: 15-22. [DOI:10.1111/j.1365-2524.2010.00942.x]
30. Kleeberger CA, Phair JP, Strathdee SA, Detels R, Kingsley L, Jacobson LP. Determinants of heterogeneous adherence to HIV-antiretroviral therapies in the multicenter AIDS cohort study. J Acquir Immune Defic Syndr 2001; 26: 82-92. [DOI:10.1097/00126334-200101010-00012]

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


© 2020 All Rights Reserved | International Journal of Reproductive BioMedicine

Designed & Developed by : Yektaweb